Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 09:43 AM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Stock Picks » Strong Buy: ADMP= MC $33 M--FDA Decision on October 31 =500%+ Potential



Reply
 
Thread Tools Search this Thread
Old 10-21-2019, 12:09 PM   Nav to Top  #1
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 264
Favorites: Aapl celg onxx
Rep Power: 108
Reputation: 36
Biohero is on a distinguished road
Default ADMP= MC $33 M--FDA Decision on October 31 =500%+ Potential

(ADMP) Market Cap $33 million--Cash $17 M --FDA Decision on Oct.31 for ZIMHI a treatment of opioid overdose which is a large market --company has already one marketed drug for the treatment of anaphylaxis launched early this year and partnered with Sandoz(Novartis) targeting a $1.5 BILLION Market .Current valuation of $33million is a PURE GIFT for this company a potential 10 bagger here . STRONG BUY SUPER AGGRESSIVE


Admamis Pharma (ADMP)

Market-Cap:$33 million
Cash: $17 million
Price: $0.54


Presentation
http://ir.adamispharmaceuticals.com/...9-920540f0cdb1


ZIMHI (naloxone) injection

Indication–Opioid Overdose

Addressable Market -$330 million

FDA action date Oct. 31, 2019





SYMJEPI (epinephrine) injection

Indication-Anaphylaxis

Addressable Market -$1.5 billion

Launched–January 2019


First products using patented, FDA-approved injection device
Both doses (0.3mg and 0.15mg) are FDA approved

Sandoz a division of Novartis –commercial partner in U.S.

Commercial deal terms –50% of net profits, upfront fee and potential performance-based milestone payments


Exploring potential licensing options for ex-US territories



Near-Term Target Milestones

FDA action date (PDUFA) of Oct. 31, 2019 on NDA for ZIMHI

Pursuing potential partnerships for SYMJEPI (ex-US) and ZIMHI product candidate

Continued launch of SYMJEPI in U.S. –retail and SYMJEPI low dose launches pending



Largest Shareholders :

Heights Capital...3.0M
683 Capital ...2.4M
The Vanguard ...1.8M
First Manhattan...1.4M
BlackRock...952.8K
Morgan Stanley...625.7K
Geode Capital...337.2K
Carlo (Dennis J)...292.3K
Moss (Ronald B)...285.0K
GSA Capital...139.6K

Biohero is offline   Rate this post Yes | No Reply With Quote
Old 10-22-2019, 10:47 AM   Nav to Top  #2
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 264
Favorites: Aapl celg onxx
Rep Power: 108
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

CHEAPEST FDA GEM ..FDA DECISION next Week guys

(ADMP) Price: $0.55 / Mkt-Cap $34 M / Cash $17 M / FDA Decision on OCTOBER 31 treatment of Opioid Overdose ....A MEGA drug which is targeting a $1.5 BILLION Market was launched early this year with partner Novartis .

https://www.rttnews.com/slideshow/38....aspx?Slide=16
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 10-23-2019, 10:36 AM   Nav to Top  #3
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 264
Favorites: Aapl celg onxx
Rep Power: 108
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

ADMP= PARTNERDEAL imminent according to management read below ..market cap of $33 million is a big joke for this company could go to over $100 million valuation on good news

https://finance.yahoo.com/news/adami...203000698.html

ZIMHI (naloxone) Injection
On March 14, 2019, Adamis announced that the FDA had accepted the company’s New Drug Application (NDA) for review and provided a target agency action date (PDUFA) of October 31, 2019. The company believes that if approved, ZIMHI could be an important part of the solution to this growing health crisis of opioid overdose. The company is in discussions with several potential partners for ZIMHI with the goal of finalizing a commercial distribution agreement for the U.S. prior to a potential approval.
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 10-23-2019, 11:40 AM   Nav to Top  #4
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 264
Favorites: Aapl celg onxx
Rep Power: 108
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

UPPPPPPPPP SHE GOESS .. and still terrible underpriced at $36 million valuation .GL

Biohero is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: IGXT (MC $48 M) FDA DECISION ON FEBRUARY 3 =500%+ Potential !!! Biohero US Penny Stock Picks 34 04-10-2015 10:37 AM
Strong Buy: AEZS (MC $67 M) (Cash $45.7M ) FDA Decision on Nov 5= 300% Potential ! Biohero US Stock Picks 5 03-26-2015 01:50 PM
Buy: TRL.TO (MC $83 M) FDA DECISION ON MAY 28 = 200% Potential !!!!! Biohero Canadian Stock Picks 0 05-20-2014 10:09 AM
Strong Buy: (NRI) Price: 0.065 // 3 Approved drugs + FDA decision on March 4 = 500%++ Potential Biohero Canadian Stock Picks 0 01-15-2013 11:05 AM
Strong Buy: (DND.T) FDA decision on 29 May /Mcap 24 M =1000% Potential ! Biohero Canadian Stock Picks 0 01-24-2012 09:02 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On